BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2298725)

  • 1. Transmodulation of epidermal growth factor binding by platelet-derived growth factor and 12-O-tetradecanoylphorbol-13-acetate is not sodium-dependent in Balb/c/3T3 cells.
    Olson JE; Pledger WJ
    J Biol Chem; 1990 Feb; 265(4):1847-51. PubMed ID: 2298725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmodulation of the epidermal-growth-factor receptor in permeabilized 3T3 cells.
    Walker F; Burgess AW
    Biochem J; 1988 Nov; 256(1):109-15. PubMed ID: 3265618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous regulation of EGF receptors in fibroblastic cells.
    Olashaw NE; Pledger WJ
    J Cell Biochem; 1987 Jun; 34(2):143-9. PubMed ID: 3496345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.
    Collins MK; Sinnett-Smith JW; Rozengurt E
    J Biol Chem; 1983 Oct; 258(19):11689-93. PubMed ID: 6311820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway.
    Wattenberg EV; McNeil PL; Fujiki H; Rosner MR
    J Biol Chem; 1989 Jan; 264(1):213-9. PubMed ID: 2562838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium as a mediator of non-phorbol tumor promoter action. Down-modulation of the epidermal growth factor receptor by palytoxin.
    Wattenberg EV; Byron KL; Villereal ML; Fujiki H; Rosner MR
    J Biol Chem; 1989 Sep; 264(25):14668-73. PubMed ID: 2570066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of platelet-derived growth factor on phosphorylation of the epidermal growth factor receptor in human skin fibroblasts.
    Decker SJ; Harris P
    J Biol Chem; 1989 Jun; 264(16):9204-9. PubMed ID: 2470752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of epidermal growth factor receptor transmodulation by platelet-derived growth factor in Chinese hamster ovary cells.
    Countaway JL; Gironès N; Davis RJ
    J Biol Chem; 1989 Aug; 264(23):13642-7. PubMed ID: 2547770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the high affinity epidermal growth factor receptor on cell-free membranes after transmodulation by platelet-derived growth factor.
    Walker F; Burgess AW
    J Biol Chem; 1991 Feb; 266(5):2746-52. PubMed ID: 1993654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of EGF receptor transmodulation in embryonal carcinoma-derived growth factor-induced mitogenesis.
    Heath JK; Mahadevan L; Foulkes JG
    EMBO J; 1986 Aug; 5(8):1809-14. PubMed ID: 3489616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts.
    Davis RJ; Czech MP
    J Biol Chem; 1987 May; 262(14):6832-41. PubMed ID: 3106361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin releasing hormone action in pituitary cells. Protein kinase C-mediated effects on the epidermal growth factor receptor.
    Kaji H; Casnellie JE; Hinkle PM
    J Biol Chem; 1988 Sep; 263(27):13588-93. PubMed ID: 2458349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
    Decker SJ; Ellis C; Pawson T; Velu T
    J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
    Imamoto A; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid.
    Winston JT; Olashaw NE; Pledger WJ
    J Cell Biochem; 1991 Sep; 47(1):79-89. PubMed ID: 1658015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding.
    Eide BL; Krebs EG; Ross R; Pike LJ; Bowen-Pope DF
    J Cell Physiol; 1986 Feb; 126(2):254-8. PubMed ID: 3003126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
    Wharton W; Leof E; Pledger WJ; O'Keefe EJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products.
    Brown KD; Blakeley DM; MacDonald M
    Biosci Rep; 1983 Jul; 3(7):659-66. PubMed ID: 6313091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism.
    Bjorge JD; Kudlow JE
    J Biol Chem; 1987 May; 262(14):6615-22. PubMed ID: 3494731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promoters.
    Murray AW; Froscio M
    Carcinogenesis; 1980 Aug; 1(8):681-4. PubMed ID: 11272121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.